Skip to main content

COVID-19 Topic Center

Video

Video
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Video
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and decision-making processes in pharmacy, and why it is…
Video
Eric Maroyka, PharmD, senior director, Center for Pharmacy Practice Advancement, ASHP, discusses the recent announcement from Pfizer regarding a successful COVID-19 vaccine, reviews the logistics of the vaccine, and highlights future challenges other vaccine trials may face that are currently…
Video
Andrea Russo, MD, director, Electrophysiology and Arrhythmia Services, Cooper Hospital, discusses why there have been delays among patients making primary care visits, along with the impact this has on diagnosis, and she provides tips for health care providers—such as pharmacists that might be…
Video
Tom Knight, CEO, Invistics, discusses the challenges that drug diversion programs address, why these programs are important during the pandemic, and offers tips for health care professionals who are looking to implement these programs into practice.
Video
Tasha Polster, vice president, pharmacy, quality, compliance and patient safety, Walgreens, discusses the measures Walgreens has taken to work with manufacturers to increase flu vaccine supply, and highlights how pharmacists can encourage and educate patients on the availability of the flu vaccine.
Video
Julie Johnson, PharmD, and Oyunbileg Magvanjav, MD, PhD, discuss the results of their recent study that explores the relationship between prescribing rates of guideline-recommended antihypertensive drug classes and blood pressure control.
Video
Deborah Levine, MD, MPH, breaks down her recent study and explains why black individuals with a higher blood pressure level may be linked to racial disparities in cognitive decline.
Video
James Chambers, PhD, associate professor of medicine, the Tufts Medical Center Institute for Clinical Research and Health Policy Studies, discusses the benefits of orphan drugs recently found in his study, and explains why orphan drugs are often less cost effective.
Video
Derek Wallace, MBBS, vice president and global dengue program head at Takeda, discusses the impact of dengue on global health and the progress of Takeda’s dengue vaccine candidate, TAK-003, including results from the ongoing pivotal Phase 3 trial and a completed Phase 2 trial recently published in…
Back to Top